Targeted lipid nanoparticles containing IL-10 mRNA improve outcomes in experimental intracerebral hemorrhage
Sahily Reyes‐Esteves(University of Pennsylvania), Tyler E. Papp(University of Pennsylvania), Marco E. Zamora(Translational Therapeutics (United States)), Carolann Espy(Translational Therapeutics (United States)), Serena Omo‐Lamai(Translational Therapeutics (United States)), Jacob W. Myerson(Translational Therapeutics (United States)), Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Manthan N. Patel(Translational Therapeutics (United States)), Awurama Akyianu(Translational Therapeutics (United States)), Aparajeeta Majumder(Translational Therapeutics (United States)), Yufei Wang(Translational Therapeutics (United States)), Hamideh Parhiz(Translational Therapeutics (United States)), Lawson Messe(Translational Therapeutics (United States)), Soomin Jeong(Translational Therapeutics (United States)), Nicolas Marzolini(Translational Therapeutics (United States))
Cited by 5
Related Papers
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
|Molecular Therapy|2021|272
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
|Small|2023|216
Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
|Advanced Materials|2024|99
Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke
|Molecular Therapy|2024|83